Centogene N.V. (CNTG) has released an update.
Centogene GmbH has entered into a KSA Receivables Transfer Agreement with Pharmaceutical Investment Company, where Centogene will transfer rights to receivables and associated rights under certain KSA Agreements. This move follows amendments to a previous loan agreement and is intended to be an absolute transfer, granting full benefits of ownership to the Pharmaceutical Investment Company without recourse to Centogene.
For further insights into CNTG stock, check out TipRanks’ Stock Analysis page.
